GSK holds block window open with $750m Aspen sale
Pharmaceutical firm GlaxoSmithKline is selling a $750m stake in South African peer Aspen Pharmacare through a block trade on Tuesday night, continuing a strong run of blocks in recent weeks.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: